The Approval Process in Action

Source: The Life Sciences Report and Visual Capitalist (5/1/13)

What catalysts in the drug development process move biotech company stocks? The savvy investor must know what steps in the U.S. Food and Drug Administration's approval process can propel a stock up or down. From drug discovery to the much-anticipated PDUFA date, The Life Sciences Report and the Visual Capitalist have collaborated on an infographic that describes both the process and related catalysts.

For news on how catalysts affect specific stocks, read the updated Life Sciences Report Watchlist.

Major Mining Company Moves to Increase Stake Ahead of Key Exploration Push
Source: Streetwise Reports (01/13/2026)

Dryden Gold Corp. (DRY:TSXV; DRYGF:OTCQB; X7W:FSE) confirmed Centerra Gold exercised its top-up right to maintain a 9.99% ownership stake following recent share issuances. Proceeds are expected to support an expanded 2026 exploration program across Drydens district-scale property in northwestern Ontario.

Drone Tech Co. Discovers Massive $163.6B Market Breakthrough in Defense Cybersecurity
Source: Streetwise Reports (01/12/2026)

Provider of cybersecurity and solutions for drones and robotics Mobilicom Ltd. (MOB:NASDAQ) announces it has secured a new design win and initial order from a customer based in the United Arab Emirates (UAE), a leading small-arms manufacturer. Find out why one analyst increased his price target on the stock.

Copper Developer Discovers Uncovers Excellent M&A Potential With Yukon's Casino Project
Source: Streetwise Reports (01/12/2026)

Western Copper and Gold Corp. (WRN:TSX; WRN:NYSE.MKT) announces the appointment of Robert Dirk as Chief Operating Officer and Christian Roldan as Vice President, Technical. Read why one analyst thinks the company could be in a position to attract larger companies.

Commercial Production Declared at a High‑Grade Red Lake Gold Mine After December Ramp‑Up
Source: Streetwise Reports (01/12/2026)

West Red Lake Gold Mines Ltd. (WRLG:TSX.V; WRLGF:OTCQX; UJO:FSE) confirmed it achieved commercial production at its 100% owned Madsen Gold Mine effective January 1, 2026, following a month that averaged 689 tonnes per day of mill throughput. The company reported US$30 million in Q4 2025 gold sales and US$73 million in full-year revenue.

AI Collaboration Expands to Accelerate Cancer Drug Discovery
Source: Streetwise Reports (01/12/2026)

Rakovina Therapeutics Inc. (RKV:TSX.V) has broadened its partnership with Variational AI to refine next-generation ATR inhibitors using generative AI. The agreement aims to streamline lead optimization for the company's kt-5000 series of small-molecule cancer drug candidates.